ID SPON1_HUMAN Reviewed; 807 AA. AC Q9HCB6; A8K6W5; O94862; Q8NCD7; Q8WUR5; DT 27-SEP-2004, integrated into UniProtKB/Swiss-Prot. DT 27-SEP-2004, sequence version 2. DT 27-MAR-2024, entry version 173. DE RecName: Full=Spondin-1; DE AltName: Full=F-spondin; DE AltName: Full=Vascular smooth muscle cell growth-promoting factor; DE Flags: Precursor; GN Name=SPON1; Synonyms=KIAA0762, VSGP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Ovary; RX PubMed=11368520; DOI=10.1006/abbi.2001.2367; RA Miyamoto K., Morishita Y., Yamazaki M., Minamino N., Kangawa K., Matsuo H., RA Mizutani T., Yamada K., Minegishi T.; RT "Isolation and characterization of vascular smooth muscle cell growth RT promoting factor from bovine ovarian follicular fluid and its cDNA cloning RT from bovine and human ovary."; RL Arch. Biochem. Biophys. 390:93-100(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 84-807, AND TISSUE SPECIFICITY. RC TISSUE=Brain; RX PubMed=9872452; DOI=10.1093/dnares/5.5.277; RA Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A., RA Kotani H., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XI. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 5:277-286(1998). RN [6] RP SEQUENCE REVISION. RX PubMed=12168954; DOI=10.1093/dnares/9.3.99; RA Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.; RT "Construction of expression-ready cDNA clones for KIAA genes: manual RT curation of 330 KIAA cDNA clones."; RL DNA Res. 9:99-106(2002). RN [7] RP GLYCOSYLATION AT TRP-448; TRP-451; TRP-507; TRP-510; TRP-564; TRP-620; RP TRP-623 AND TRP-674. RX PubMed=12096136; DOI=10.1074/mcp.m100011-mcp200; RA Gonzalez de Peredo A., Klein D., Macek B., Hess D., Peter-Katalinic J., RA Hofsteenge J.; RT "C-mannosylation and O-fucosylation of thrombospondin type 1 repeats."; RL Mol. Cell. Proteomics 1:11-18(2002). RN [8] RP X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 40-186, AND DISULFIDE BONDS. RX PubMed=19020352; DOI=10.1107/s0907444908028308; RA Nagae M., Nishikawa K., Yasui N., Yamasaki M., Nogi T., Takagi J.; RT "Structure of the F-spondin reeler domain reveals a unique beta-sandwich RT fold with a deformable disulfide-bonded loop."; RL Acta Crystallogr. D 64:1138-1145(2008). RN [9] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 29-194, AND DISULFIDE BONDS. RX PubMed=18602404; DOI=10.1016/j.jmb.2008.06.045; RA Tan K., Duquette M., Liu J.H., Lawler J., Wang J.H.; RT "The crystal structure of the heparin-binding reelin-N domain of f- RT spondin."; RL J. Mol. Biol. 381:1213-1223(2008). RN [10] RP X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 191-434 IN COMPLEX WITH CALCIUM, RP DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-214. RX PubMed=21569239; DOI=10.1186/1472-6807-11-22; RA Tan K., Lawler J.; RT "The structure of the Ca+-binding, glycosylated F-spondin domain of F- RT spondin - A C2-domain variant in an extracellular matrix protein."; RL BMC Struct. Biol. 11:22-22(2011). CC -!- FUNCTION: Cell adhesion protein that promotes the attachment of spinal CC cord and sensory neuron cells and the outgrowth of neurites in vitro. CC May contribute to the growth and guidance of axons in both the spinal CC cord and the PNS (By similarity). Major factor for vascular smooth CC muscle cell. {ECO:0000250}. CC -!- SUBUNIT: Binds to the central extracellular domain of APP and inhibits CC beta-secretase cleavage of APP. {ECO:0000250}. CC -!- INTERACTION: CC Q9HCB6; P05067-4: APP; NbExp=3; IntAct=EBI-2431846, EBI-302641; CC Q9HCB6; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-2431846, EBI-3867333; CC Q9HCB6; Q99750: MDFI; NbExp=3; IntAct=EBI-2431846, EBI-724076; CC Q9HCB6; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-2431846, EBI-16439278; CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix {ECO:0000250}. CC -!- TISSUE SPECIFICITY: Highest expression in lung, lower expression in CC brain, heart, kidney, liver and testis, and lowest expression in CC pancreas, skeletal muscle and ovary. Not expressed in spleen. CC {ECO:0000269|PubMed:11368520, ECO:0000269|PubMed:9872452}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB051390; BAB18461.1; -; mRNA. DR EMBL; AK074803; BAC11217.1; -; mRNA. DR EMBL; AK291780; BAF84469.1; -; mRNA. DR EMBL; CH471064; EAW68488.1; -; Genomic_DNA. DR EMBL; CH471064; EAW68489.1; -; Genomic_DNA. DR EMBL; BC019825; AAH19825.1; -; mRNA. DR EMBL; BC136513; AAI36514.1; -; mRNA. DR EMBL; BC136563; AAI36564.1; -; mRNA. DR EMBL; AB018305; BAA34482.2; -; mRNA. DR CCDS; CCDS73262.1; -. DR RefSeq; NP_006099.2; NM_006108.3. DR PDB; 2ZOT; X-ray; 2.70 A; A/B/C/D=29-198. DR PDB; 2ZOU; X-ray; 1.45 A; A/B=40-186. DR PDB; 3COO; X-ray; 2.00 A; A/B=29-194. DR PDB; 3Q13; X-ray; 1.95 A; A=191-434. DR PDBsum; 2ZOT; -. DR PDBsum; 2ZOU; -. DR PDBsum; 3COO; -. DR PDBsum; 3Q13; -. DR AlphaFoldDB; Q9HCB6; -. DR SMR; Q9HCB6; -. DR BioGRID; 115687; 25. DR IntAct; Q9HCB6; 7. DR STRING; 9606.ENSP00000460236; -. DR GlyConnect; 1768; 5 N-Linked glycans (1 site). DR GlyCosmos; Q9HCB6; 13 sites, 7 glycans. DR GlyGen; Q9HCB6; 14 sites, 5 N-linked glycans (1 site), 3 O-linked glycans (4 sites). DR iPTMnet; Q9HCB6; -. DR PhosphoSitePlus; Q9HCB6; -. DR BioMuta; SPON1; -. DR DMDM; 52783472; -. DR EPD; Q9HCB6; -. DR jPOST; Q9HCB6; -. DR MassIVE; Q9HCB6; -. DR PaxDb; 9606-ENSP00000460236; -. DR PeptideAtlas; Q9HCB6; -. DR ProteomicsDB; 81664; -. DR Pumba; Q9HCB6; -. DR Antibodypedia; 62004; 178 antibodies from 26 providers. DR DNASU; 10418; -. DR Ensembl; ENST00000576479.4; ENSP00000460236.1; ENSG00000262655.4. DR GeneID; 10418; -. DR KEGG; hsa:10418; -. DR MANE-Select; ENST00000576479.4; ENSP00000460236.1; NM_006108.4; NP_006099.2. DR UCSC; uc031xfv.2; human. DR AGR; HGNC:11252; -. DR CTD; 10418; -. DR DisGeNET; 10418; -. DR GeneCards; SPON1; -. DR HGNC; HGNC:11252; SPON1. DR HPA; ENSG00000262655; Low tissue specificity. DR MIM; 604989; gene. DR neXtProt; NX_Q9HCB6; -. DR OpenTargets; ENSG00000262655; -. DR PharmGKB; PA36082; -. DR VEuPathDB; HostDB:ENSG00000262655; -. DR eggNOG; KOG3539; Eukaryota. DR GeneTree; ENSGT00940000154910; -. DR HOGENOM; CLU_014540_1_0_1; -. DR InParanoid; Q9HCB6; -. DR OMA; MMPPKEG; -. DR OrthoDB; 5404502at2759; -. DR PhylomeDB; Q9HCB6; -. DR PathwayCommons; Q9HCB6; -. DR Reactome; R-HSA-5083635; Defective B3GALTL causes PpS. DR Reactome; R-HSA-5173214; O-glycosylation of TSR domain-containing proteins. DR SignaLink; Q9HCB6; -. DR SIGNOR; Q9HCB6; -. DR BioGRID-ORCS; 10418; 9 hits in 255 CRISPR screens. DR ChiTaRS; SPON1; human. DR EvolutionaryTrace; Q9HCB6; -. DR GeneWiki; Spondin_1; -. DR GenomeRNAi; 10418; -. DR Pharos; Q9HCB6; Tbio. DR PRO; PR:Q9HCB6; -. DR Proteomes; UP000005640; Chromosome 11. DR RNAct; Q9HCB6; Protein. DR Bgee; ENSG00000262655; Expressed in gall bladder and 195 other cell types or tissues. DR GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome. DR GO; GO:0031012; C:extracellular matrix; IBA:GO_Central. DR GO; GO:0005615; C:extracellular space; HDA:BHF-UCL. DR GO; GO:0005201; F:extracellular matrix structural constituent; ISS:BHF-UCL. DR GO; GO:0050693; F:LBD domain binding; IEA:Ensembl. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0007155; P:cell adhesion; IBA:GO_Central. DR GO; GO:1902430; P:negative regulation of amyloid-beta formation; IEA:Ensembl. DR GO; GO:1902993; P:positive regulation of amyloid precursor protein catabolic process; IEA:Ensembl. DR GO; GO:0010954; P:positive regulation of protein processing; IEA:Ensembl. DR GO; GO:0016485; P:protein processing; IEA:Ensembl. DR CDD; cd08544; Reeler; 1. DR Gene3D; 2.60.40.2130; F-spondin domain; 1. DR Gene3D; 2.60.40.4060; Reeler domain; 1. DR Gene3D; 2.20.100.10; Thrombospondin type-1 (TSP1) repeat; 6. DR InterPro; IPR002861; Reeler_dom. DR InterPro; IPR042307; Reeler_sf. DR InterPro; IPR009465; Spondin_N. DR InterPro; IPR038678; Spondin_N_sf. DR InterPro; IPR000884; TSP1_rpt. DR InterPro; IPR036383; TSP1_rpt_sf. DR InterPro; IPR044004; TSP1_spondin_dom. DR NCBIfam; NF038123; NF038123_dom; 1. DR PANTHER; PTHR11311; SPONDIN; 1. DR PANTHER; PTHR11311:SF16; SPONDIN-1; 1. DR Pfam; PF02014; Reeler; 1. DR Pfam; PF06468; Spond_N; 1. DR Pfam; PF19028; TSP1_spondin; 1. DR Pfam; PF00090; TSP_1; 5. DR SMART; SM00209; TSP1; 6. DR SUPFAM; SSF82895; TSP-1 type 1 repeat; 6. DR PROSITE; PS51019; REELIN; 1. DR PROSITE; PS51020; SPONDIN; 1. DR PROSITE; PS50092; TSP1; 6. DR Genevisible; Q9HCB6; HS. PE 1: Evidence at protein level; KW 3D-structure; Cell adhesion; Disulfide bond; Extracellular matrix; KW Glycoprotein; Metal-binding; Reference proteome; Repeat; Secreted; Signal. FT SIGNAL 1..28 FT /evidence="ECO:0000255" FT CHAIN 29..807 FT /note="Spondin-1" FT /id="PRO_0000035865" FT DOMAIN 29..194 FT /note="Reelin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00363" FT DOMAIN 195..388 FT /note="Spondin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00364" FT DOMAIN 442..495 FT /note="TSP type-1 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DOMAIN 501..555 FT /note="TSP type-1 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DOMAIN 558..611 FT /note="TSP type-1 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DOMAIN 614..666 FT /note="TSP type-1 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DOMAIN 668..721 FT /note="TSP type-1 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DOMAIN 754..806 FT /note="TSP type-1 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT BINDING 325 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:21569239, FT ECO:0007744|PDB:3Q13" FT BINDING 354 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:21569239, FT ECO:0007744|PDB:3Q13" FT BINDING 358 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:21569239, FT ECO:0007744|PDB:3Q13" FT CARBOHYD 214 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:21569239, FT ECO:0007744|PDB:3Q13" FT CARBOHYD 448 FT /note="C-linked (Man) tryptophan" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 451 FT /note="C-linked (Man) tryptophan; partial" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 507 FT /note="C-linked (Man) tryptophan" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 510 FT /note="C-linked (Man) tryptophan; partial" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 564 FT /note="C-linked (Man) tryptophan" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 620 FT /note="C-linked (Man) tryptophan; partial" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 623 FT /note="C-linked (Man) tryptophan" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 674 FT /note="C-linked (Man) tryptophan" FT /evidence="ECO:0000269|PubMed:12096136" FT CARBOHYD 681 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 44..128 FT /evidence="ECO:0000269|PubMed:18602404, FT ECO:0000269|PubMed:19020352, ECO:0007744|PDB:2ZOT, FT ECO:0007744|PDB:2ZOU, ECO:0007744|PDB:3COO" FT DISULFID 156..182 FT /evidence="ECO:0000269|PubMed:18602404, FT ECO:0000269|PubMed:19020352, ECO:0007744|PDB:2ZOT, FT ECO:0007744|PDB:2ZOU, ECO:0007744|PDB:3COO" FT DISULFID 199..336 FT /evidence="ECO:0000269|PubMed:21569239, FT ECO:0007744|PDB:3Q13" FT DISULFID 200..340 FT /evidence="ECO:0000269|PubMed:21569239, FT ECO:0007744|PDB:3Q13" FT DISULFID 202..415 FT /evidence="ECO:0000269|PubMed:21569239, FT ECO:0007744|PDB:3Q13" FT DISULFID 443..480 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 454..489 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 459..494 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 502..538 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 513..517 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 548..554 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 559..595 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 570..574 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 605..610 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 615..650 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 626..630 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT DISULFID 660..665 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00210" FT CONFLICT 500 FT /note="S -> P (in Ref. 2; BAC11217)" FT /evidence="ECO:0000305" FT CONFLICT 545 FT /note="T -> M (in Ref. 1; BAB18461)" FT /evidence="ECO:0000305" FT CONFLICT 570 FT /note="C -> Y (in Ref. 2; BAC11217)" FT /evidence="ECO:0000305" FT CONFLICT 605 FT /note="C -> R (in Ref. 2; BAC11217)" FT /evidence="ECO:0000305" FT CONFLICT 695 FT /note="I -> T (in Ref. 4; AAH19825)" FT /evidence="ECO:0000305" FT CONFLICT 729 FT /note="L -> P (in Ref. 1; BAB18461)" FT /evidence="ECO:0000305" FT TURN 43..46 FT /evidence="ECO:0007829|PDB:3COO" FT TURN 48..50 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 60..65 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 70..72 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 77..84 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 90..99 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 104..106 FT /evidence="ECO:0007829|PDB:3COO" FT HELIX 107..109 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 112..117 FT /evidence="ECO:0007829|PDB:2ZOU" FT TURN 119..121 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 122..125 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 128..136 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 140..148 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 157..169 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 173..175 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 178..181 FT /evidence="ECO:0007829|PDB:2ZOU" FT STRAND 203..213 FT /evidence="ECO:0007829|PDB:3Q13" FT TURN 217..219 FT /evidence="ECO:0007829|PDB:3Q13" FT TURN 226..228 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 234..239 FT /evidence="ECO:0007829|PDB:3Q13" FT HELIX 254..262 FT /evidence="ECO:0007829|PDB:3Q13" FT HELIX 266..273 FT /evidence="ECO:0007829|PDB:3Q13" FT HELIX 274..278 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 279..285 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 288..291 FT /evidence="ECO:0007829|PDB:3Q13" FT TURN 295..297 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 302..311 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 313..322 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 324..334 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 340..342 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 344..350 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 356..358 FT /evidence="ECO:0007829|PDB:3Q13" FT STRAND 401..412 FT /evidence="ECO:0007829|PDB:3Q13" SQ SEQUENCE 807 AA; 90973 MW; CEA84A83F206A5A5 CRC64; MRLSPAPLKL SRTPALLALA LPLAAALAFS DETLDKVPKS EGYCSRILRA QGTRREGYTE FSLRVEGDPD FYKPGTSYRV TLSAAPPSYF RGFTLIALRE NREGDKEEDH AGTFQIIDEE ETQFMSNCPV AVTESTPRRR TRIQVFWIAP PAGTGCVILK ASIVQKRIIY FQDEGSLTKK LCEQDSTFDG VTDKPILDCC ACGTAKYRLT FYGNWSEKTH PKDYPRRANH WSAIIGGSHS KNYVLWEYGG YASEGVKQVA ELGSPVKMEE EIRQQSDEVL TVIKAKAQWP AWQPLNVRAA PSAEFSVDRT RHLMSFLTMM GPSPDWNVGL SAEDLCTKEC GWVQKVVQDL IPWDAGTDSG VTYESPNKPT IPQEKIRPLT SLDHPQSPFY DPEGGSITQV ARVVIERIAR KGEQCNIVPD NVDDIVADLA PEEKDEDDTP ETCIYSNWSP WSACSSSTCD KGKRMRQRML KAQLDLSVPC PDTQDFQPCM GPGCSDEDGS TCTMSEWITW SPCSISCGMG MRSRERYVKQ FPEDGSVCTL PTEETEKCTV NEECSPSSCL MTEWGEWDEC SATCGMGMKK RHRMIKMNPA DGSMCKAETS QAEKCMMPEC HTIPCLLSPW SEWSDCSVTC GKGMRTRQRM LKSLAELGDC NEDLEQVEKC MLPECPIDCE LTEWSQWSEC NKSCGKGHVI RTRMIQMEPQ FGGAPCPETV QRKKCRIRKC LRNPSIQKLR WREARESRRS EQLKEESEGE QFPGCRMRPW TAWSECTKLC GGGIQERYMT VKKRFKSSQF TSCKDKKEIR ACNVHPC //